Pennsylvania Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 1 - 8 of 8
ASTELLAS PHARMA INC. et al v. QILU PHARMA, INC. et al
as 2:2023cv00125
Plaintiff: ASTELLAS PHARMA INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant: QILU PHARMA, INC. and QILU PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD et al
as 2:2021cv00573
Plaintiff: BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC
Defendant: AGILA SPECIALTIES INC, MYLAN INC, VIATRIS INC and others
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC.
as 2:2021cv00564
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: Qila Pharma Inc. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 2:2020cv02545
Plaintiff: BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Defendant: HEC PHARM USA and HEC PHARM CO., LTD.
Cause Of Action: 35 U.S.C. § 271
PFIZER, INC. et al v. QILU PHARMA, INC. et al
as 2:2019cv01846
Defendant: QILU PHARMA, INC. and QILU PHARMACEUTICAL CO., LTD.
Plaintiff: PFIZER MANUFACTURING HOLDINGS LLC, PFIZER PFE IRELAND PHARMACEUTICALS HOLDING 1 B.V., WARNER-LAMBERT COMPANY LLC and others
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. KVK-TECH, INC.
as 2:2018cv04195
Plaintiff: DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD. and others
Defendant: KVK-TECH, INC.
Cause Of Action: 35 U.S.C. § 271
H. LUNDBECK A/S et al v. SIGMAPHARM LABORATORIES, LLC
as 2:2018cv01880
Plaintiff: H. LUNDBECK A/S , TAKEDA PHARMACEUTICAL COMPANY LTD. , TAKEDA PHARMACEUTICALS U.S.A., INC. and others
Defendant: SIGMAPHARM LABORATORIES, LLC
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. v. MYLAN LABORATORIES LIMITED
as 2:2018cv01334
Plaintiff: MERCK SHARP & DOHME CORP.
Defendant: MYLAN LABORATORIES LIMITED
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?